Headquartered in New Haven, CT,Achillion applies expertise in biology and structure-guided design and a deep understanding of patient and clinician needs to develop innovative treatment solutions aimed at improving the lives of patients. More...
Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Click to learn more about this disease.
2015 Cowen Health Care Conference
Achillion Pharmaceuticals Announces Closing of Public Offering of Common Stock
Achillion Pharmaceuticals Announces Pricing of Public Offering of Common Stock